Navigation Links
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:1/16/2012

NEW YORK, Jan. 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0761195/Insulin-Delivery-Devices---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary GlobalData's new report, "Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global insulin delivery devices market. The report provides market landscape, competitive landscape and market trends information on the insulin delivery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.- Key segments covered include Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.- Qualitative analysis of key market trends, market drivers, and restraints within the insulin delivery devices market. - The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. - Key players covered include Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company, Becton, Dickinson and Company and F. Hoffmann-La Roche Ltd.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the insulin delivery devices globally.- Design and develop your product development, marketing and sales strategies.- Develop market-entry and market expansion strategies.- Identify key players best positioned to take advantage of the emerging market opportunities.- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.- What's the next big thing in the insulin delivery devices market landscape? – Identify, understand and capitalize.- Make more informed business decisions from the insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.1 Table of Contents1 Table of Contents 31.1 List of Tables 51.2 List of Figures 62 Introduction 82.1 GlobalData Report Guidance 83 Disease Overview - Diabetes 93.1 Types of Diabetes 93.1.1 Type 1 Diabetes 93.1.2 Type 2 Diabetes 93.1.3 Gestational Diabetes 93.2 Signs and Symptoms 93.3 Diagnosis 103.3.1 Fasting Plasma Glucose Test 103.3.2 Oral Glucose Tolerance Test 103.3.3 Random Plasma Glucose Test 103.4 Epidemiology 113.4.1 Epidemiology of Diabetes in the US 123.4.2 Epidemiology of Diabetes in the UK 123.4.3 Epidemiology of Diabetes in Japan 123.4.4 Epidemiology of Diabetes in India 123.4.5 Epidemiology of Diabetes in China 124 Insulin Delivery Devices - Overview 134.1 Insulin Delivery Devices, Market Segmentation 134.1.1 Insulin Pen 134.1.2 Insulin Pump 144.1.3 Insulin Syringe 144.1.4 Traditional Insulin Pump Accessories 144.2 Comparison of Insulin Delivery Devices 155 Insulin Delivery Devices - Global Market Characterization 165.1 Insulin Delivery Devices Market, Global, Revenue ($bn), Historic, 2003-2010 165.2 Insulin Delivery Devices Market, Global, Revenue ($bn), Forecast, 2010-2017 175.3 Global Insulin Delivery Devices Market, Key Trends 185.3.1 More People Use Insulin Pumps in the US than in European Countries, where Insulin Pens are the Preferred Choice 185.3.2 Disposable Insulin Pumps to Gain Market Share at the Expense of Traditional Insulin Pumps 185.3.3 Partnerships between Insulin Manufacturers and Insulin Delivery Devices Companies is a Recent Trend in the Insulin Delivery Devices Market 195.3.4 Food and Drug Administration to Tighten the Regulation of Infusion Pumps 205.3.5 Co-Marketing of Insulin Pumps with Blood Glucose Monitoring/Continuous Glucose Monitor Devices is a Recent Market Trend 215.3.6 Artificial Pancreas to be a Future Trend in the Insulin Pumps Market 215.4 Global Insulin Delivery Devices, Market Dynamics 245.4.1 Market Drivers 245.4.2 Market Restraints 276 Global Insulin Delivery Devices Market - Analysis by Segment 296.1 Insulin Pens, Global, Revenue ($m), Historic, 2003-2010 296.2 Insulin Pens, Global, Revenue ($m), Forecast, 2010-2017 306.2.1 Market Drivers 316.2.2 Market Restraints 336.3 Insulin Pumps, Global, Revenue ($m), Historic, 2003-2010 346.4 Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017 356.4.1 Market Drivers 366.4.2 Market Restraints 376.5 Insulin Syringes, Global, Revenue ($m), Historic, 2003-2010 386.6 Insulin Syringes, Global, Revenue ($m), Forecast, 2010-2017 396.6.1 Market Drivers 406.6.2 Market Restraints 406.7 Traditional Insulin Pump Accessories, Global, Revenue ($bn), History, 2003-2010 416.8 Traditional Insulin Pump Accessories, Global, Revenue ($bn), Forecast, 2010-2017 427 Insulin Delivery Devices Market - Analysis and Forecasts by Country, Revenue ($m), 2003-2017 437.1 Insulin Delivery Devices Market, The US, Revenue ($m), Historic, 2003-2010 437.2 Insulin Delivery Devices Market, The US, Revenue ($m), Forecast, 2010-2017 447.3 Insulin Delivery Devices Market, Canada, Revenue ($m), Historic, 2003-2010 457.4 Insulin Delivery Devices Market, Canada, Revenue ($m), Forecast, 2010-2017 467.5 Insulin Delivery Devices Market, The UK, Revenue ($m), Historic, 2003-2010 507.6 Insulin Delivery Devices Market, The UK, Revenue ($m), Forecast, 2010-2017 517.7 Insulin Delivery Devices Market, Germany, Revenue ($m), Historic, 2003-2010 527.8 Insulin Delivery Devices Market, Germany, Revenue ($m), Forecast, 2010-2017 537.9 Insulin Delivery Devices Market, France, Revenue ($m), Historic, 2003-2010 547.10 Insulin Delivery Devices Market, France, Revenue ($m), Forecast, 2010-2017 557.11 Insulin Delivery Devices Market, Italy, Revenue ($m), Historic, 2003-2010 567.12 Insulin Delivery Devices Market, Italy, Revenue ($m), Forecast, 2010-2017 577.13 Insulin Delivery Devices Market, Spain, Revenue ($m), Historic, 2003-2010 587.14 Insulin Delivery Devices Market, Spain, Revenue ($m), Forecast, 2010–2017 597.15 Insulin Delivery Devices Market, Japan, Revenue ($m), Historic, 2003-2010 607.16 Insulin Delivery Devices Market, Japan, Revenue ($m), Forecast, 2010-2017 617.17 Insulin Delivery Devices Market, China, Revenue ($m), Historic, 2003-2010 627.18 Insulin Delivery Devices Market, China, Revenue ($m), Forecast, 2010-2017 637.19 Insulin Delivery Devices Market, India, Revenue ($'000), Historic, 2003-2010 647.20 Insulin Delivery Devices Market, India, Revenue ($'000), Forecast, 2010-2017 657.21 Insulin Delivery Devices Market, Australia, Revenue ($m), Historic, 2003-2010 667.22 Insulin Delivery Devices Market, Australia, Revenue ($m), Forecast, 2010-2017 677.23 Insulin Delivery Devices Market, Brazil, Revenue ($m), Historic, 2003-2010 687.24 Insulin Delivery Devices Market, Brazil, Revenue ($m), Forecast, 2010-2017 698 Global Insulin Delivery Devices Market - Competitive Assessment 708.1 Insulin Delivery Devices Market, Global, Key Company Share (%), 2010 708.2 Insulin Delivery Devices, Global, Key Market Participants 718.2.1 Medtronic Inc. 718.2.2 Novo Nordisk A/S 738.2.3 Sanofi 758.2.4 Eli Lilly and Company 778.2.5 Becton, Dickinson and Company 788.2.6 F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG) 809 Insulin Delivery Devices - Pipeline Assessment 819.1 Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 819.2 Pipeline Assessment by Developmental Stage and Territory, 2011 829.2.1 Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011 829.2.2 Key Pipeline Products, Insulin Pumps 849.2.3 Insulin Pens, Pipeline by Developmental Stage and Territory, 2011 929.2.4 Key Pipeline Products, Insulin Pens 929.2.5 Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011 939.2.6 Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011 939.2.7 Key Pipeline Products, Other Insulin Delivery Devices 9410 Global Insulin Delivery Devices Market - Strategic Deals Analysis 9610.1 Key Deals, Insulin Delivery Devices Market 9610.1.1 Haselmeier Enters into Distribution Agreement with Biocon 9610.1.2 Cellnovo Enters into Technology Integration Agreement with LifeScan 9610.1.3 Insulet Announces Acquisition of Neighborhood Diabetes 9710.1.4 Insulet Enters into Distribution Agreement with GlaxoSmithKline 9710.1.5 Cellnovo Enters into Agreement with Home Diagnostics 9710.1.6 Roche Holding Acquires Medingo from Elron Electronic Industries 9710.1.7 JDRF Enters into Agreement with Becton, Dickinson and Company 9810.1.8 Insulet Enters into Distribution Agreement with Ypsomed Holding 9811 Appendix 9911.1 Market Definitions 9911.1.1 Insulin Delivery Devices 9911.2 Abbreviations 10011.3 Research Methodology 10211.3.1 Secondary Research 10211.3.2 Primary Research 10211.3.3 Models 10311.3.4 Forecasts 10311.3.5 Expert Panel 10311.4 GlobalData Consulting 10311.5 Contact Us 10311.6 Disclaimer 10411.7 Sources 104

List of Tables

Table 1: Fasting Plasma Glucose Test 10Table 2: Oral Glucose Tolerance Test 10Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 10Table 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011 11Table 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010 16Table 6: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017 17Table 7: Insulin Pumps Market, Global, 2006-2010 19Table 8: Organizations/Companies Developing Artificial Pancreas 22Table 9: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005 24Table 10: Studies Indicating Safety and Efficacy of Insulin Pumps 25Table 11: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 and 2009 27Table 12: Insulin Pens, Global, Revenue ($m), 2003-2010 29Table 13: Insulin Pens, Global, Revenue ($m), 2010-2017 30Table 14: Studies Suggesting Advantages of Insulin Pens Over Insulin Syringes, 2008-2011 31Table 15: Studies Suggesting Better Patient Compliance with Insulin Pens than Insulin Syringes, 2007-2010 33Table 16: Insulin Pumps, Global, Revenue ($m), 2003-2010 34Table 17: Insulin Pumps, Global, Revenue ($m), 2010-2017 35Table 18: Studies Indicating Safety and Efficacy of Insulin Pump Therapy in Pregnant Women, 2001-2011 36Table 19: Insulin Syringes, Global, Revenue ($m), 2003-2010 38Table 20: Insulin Syringes, Global, Revenue ($m), 2010-2017 39Table 21: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010 41Table 22: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017 42Table 23: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010 43Table 24: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017 44Table 25: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010 45Table 26: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017 46Table 27: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011 47>Table 28: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 48Table 29: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 49Table 30: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010 50Table 31: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017 51Table 32: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010 52Table 33: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017 53Table 34: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010 54Table 35: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017 55Table 36: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010 56Table 37: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017 57Table 38: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010 58Table 39: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010-2017 59Table 40: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010 60Table 41: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017 61Table 42: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010 62Table 43: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017 63Table 44: Insulin Delivery Devices Market, India, Revenue ($'000), 2003-2010 64Table 45: Insulin Delivery Devices Market, India, Revenue ($'000), 2010-2017 65Table 46: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010 66Table 47: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017 67Table 48: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010 68Table 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017 69Table 50: Insulin Delivery Devices Market, Global, Key Company Revenue ($m), 2010 70Table 51: Pipeline Products, Medtronic Inc. 72Table 52: Key Insulin Delivery Products, Medtronic Inc. 73Table 53: Key Insulin Delivery Products, Novo Nordisk A/S 75Table 54: Key Insulin Delivery Products, Sanofi 76Table 55: Key Insulin Delivery Products, Eli Lilly and Company 78Table 56: Insulin Delivery Devices, Becton, Dickinson and Company 79Table 57: Key Insulin Delivery Products, Becton, Dickinson and Company 79Table 58: Key Insulin Delivery Products, Disetronic Medical Systems AG 80Table 59: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81Table 60: Insulin Pumps, Pipeline by Developmental Stage and Territory, 2011 82Table 61: Artificial Pancreas System (Boston University), Clinical Trial Details 84Table 62: Artificial Pancreas System (University of Virginia), Clinical Trial Details 87Table 63: Paradigm Veo System, Clinical Trial Details 90Table 64: Insulin Pens, Pipeline by Developmental Stage and Territory, 2011 92Table 65: NovoPen Echo, Clinical Trial Details 92Table 66: Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011 93Table 67: Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011 93Table 68: AFREZZA - Medtone Inhaler, Clinical Trial Details 94Table 69: Key Deals, Insulin Delivery Devices Market, 2009-2011 96

List of Figures

Figure 1: Diabetes Prevalence (%), Global, 2011 11Figure 2: Insulin Delivery Devices, Market Segmentation 13Figure 3: Comparison of Insulin Delivery Devices 15Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010 16Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017 17Figure 6: Insulin Pumps Market, Global, 2006-2010 18Figure 7: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies 19Figure 8: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies 21Figure 9: Global Insulin Delivery Devices, Market Dynamics 24Figure 10: Causes of Type 1 Diabetes in Children 25Figure 11: Insulin Pens, Global, Revenue ($m), 2003-2010 29Figure 12: Insulin Pens, Global, Revenue ($m), 2010-2017 30Figure 13: Patient Perception Analysis for Insulin Pens and Insulin Syringes 32Figure 14: Insulin Pumps, Global, Revenue ($m), 2003-2010 34Figure 15: Insulin Pumps, Global, Revenue ($m), 2010-2017 35Figure 16: Insulin Syringes, Global, Revenue ($m), 2003-2010 38Figure 17: Insulin Syringes, Global, Revenue ($m), 2010-2017 39Figure 18: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010 41Figure 19: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017 42Figure 20: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010 43Figure 21: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017 44Figure 22: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010 45Figure 23: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017 46Figure 24: Individual Out-of-Pocket Expenses for Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011 47>Figure 25: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 48Figure 26: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 49Figure 27: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010 50Figure 28: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017 51Figure 29: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010 52Figure 30: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017 53Figure 31: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010 54Figure 32: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017 55Figure 33: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010 56Figure 34: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017 57Figure 35: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010 58Figure 36: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010–2017 59Figure 37: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010 60Figure 38: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017 61Figure 39: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010 62Figure 40: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017 63Figure 41: Insulin Delivery Devices Market, India, Revenue ($'000), 2003-2010 64Figure 42: Insulin Delivery Devices Market, India, Revenue ($'000), 2010-2017 65Figure 43: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010 66Figure 44: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017 67Figure 45: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010 68Figure 46: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017 69Figure 47: Insulin Delivery Devices Market, Global, Key Company Share (%), 2010 70Figure 48: Insulin Delivery Devices Market, Competitive Assessment 71Figure 49: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81Figure 50: Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011 82

Companies mentioned

Medtronic Inc.

Novo Nordisk A/S

Sanofi

Eli Lilly and Company

Becton, Dickinson and Company

F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG)

To order this report:Drug Delivery Technology Industry: Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

More  

Market Research Report

Check our  

Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
2. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
3. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
4. Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial
5. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
6. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
7. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
8. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
9. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
10. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
11. Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):